Onconetix, Inc. Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)
Onconetix, Inc. (ONCO) reported Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) of $75.91 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-12-10.
Financial Statements › Income Statement › Other Income
us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss · last filed 2024-12-10
- Onconetix, Inc. finite lived intangible assets, foreign currency translation gain (loss) for the quarter ending 2024-09-30 was -$1.34M.
- Onconetix, Inc. finite lived intangible assets, foreign currency translation gain (loss) for the quarter ending 2024-06-30 was -$72.42K.
- Onconetix, Inc. finite lived intangible assets, foreign currency translation gain (loss) for the quarter ending 2024-03-31 was $1.49M.
- Onconetix, Inc. finite lived intangible assets, foreign currency translation gain (loss) for fiscal 2023 was $701.06K.
| Period end | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 3 month | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 6 month | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 9 month | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-10 | -$1.41M derived: sum of 2 quarters · filed 2024-12-10 | $75.91K 10-Q · filed 2024-12-10 | |
| 2024-06-30 | -$72.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-29 | $1.42M 10-Q · filed 2024-08-29 | ||
| 2024-03-31 | $1.49M 10-Q · filed 2024-05-20 | |||
| 2023-12-31 | $701.06K 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |